YK Bioventures is a venture capital firm backing U.S. biotechnology and life sciences companies, with investment activity from seed and early-stage rounds through later-stage financings. The firm is most relevant for founders building therapeutics, drug-development and pharmaceutical platforms, including small-molecule, RNA, cell therapy and gene-regulation approaches.